Clinical researchers in the Americas have submitted essays for this year's competition and on 15 March, the authors and finalists will be identified at a meeting of the executive steering group.

Stage 2 entries are up 55% on 2017, with more entrants through than at any time in the last five years. Commenting on this development, Mark Lacy, co-chair of the executive steering group says:  “I’m looking forward to finding out which outstanding individuals and teams submitted this year’s top essays - I’ve got no doubt that this is going to be one of the most exciting competitions to date.”

Organiser PharmaTimes Media sends all of the essays to the judges without telling them who they have been written by, so that they can mark freely and without bias.

Marking now complete, the authors and the companies they work for will be revealed at the meeting of the executive steering group next week  – in what is often referred to as ‘the unblinding of the essays’. The top performers will then be invited to compete in Stage 3 of the competition: The Finals.

“Taking place on April 29 at the Hyatt Regency Crystal City in Washington DC, the finals will allow qualifying clinical researchers to complete on-the-day challenges, presenting to judging panels who will record scores across a number of parameters providing both quantitative and qualitative feedback to help candidates improve their performance,” says PharmaTimes business manager and competition lead Anna Yeardley.

The Awards Ceremony will take place at the same venue in the evening and will bring together an audience of over 100 senior clinical decision makers. It is photographed with live social media updates, so the success of all the finalists can be broadcast through global PR channels.

The dress code for the Awards Ceremony is Black Tie/Tuxedo.

For more information and to book tickets visit